Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis.

By D. Perkins, H. Gu, K. Boteva, J. Lieberman. American Journal of Psychiatry, 2005

1,295 citations recorded by the source corpus.

Subfields: Clinical Psychology, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/876e8cb66f0444ac8bc1cea8a80a6b96e458f847

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Clinical Psychology

1. Matcheri S. Keshavan
2. R. Tandon
3. H. Nasrallah

In Psychiatry and Mental health

1. Hans-Jürgen Möller
2. Meng Liang
3. Matcheri S. Keshavan
4. T. Jiang
5. R. Tandon
6. H. Nasrallah

Citations in the corpus

• World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance (2012, background): “Meta-analyses and systematic reviews from both the same group and other groups confi rmed that shorter duration of untreated psychosis was associated with better response to antipsychotic treatment (Marshall et al. 2005; Perkins et al. 2005).”
• Schizophrenia, "just the facts" 4. Clinical features and conceptualization. (2009, positive): “(2009), doi:10.1016/j.schres.2009.03.005 Perkins et al., 2005; Clarke et al., 2006; Malla et al., 2006; Farooq et al., in press) suggesting that untreated psychosis may be biologically noxious (Wyatt and Hunter, 2001).”
• Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis (2014, neutral): “3 Some studies with remarkably different definitions of DUP were excluded from the meta-analysis.”
• Disrupted small-world networks in schizophrenia. (2008, background): “, 2007), duration of non-treatment (Perkins et al., 2005) and medication (Strous et al.”